Table 1 Baseline and clinical characteristics of patients with and without PE.
Variables | Total (n = 2929) | PE (n = 1198) | No PE (n = 1731) | P value |
|---|---|---|---|---|
Age - years | 57.0 ± 15.2 | 59.2 ± 14.5 | 55.4 ± 15.5 | < 0.001 |
Male | 1385 (47.3%) | 595 (49.7%) | 790 (45.6%) | 0.035 |
Heart rate - bpm | ||||
≤ 100 | 2633 (89.9%) | 1024 (85.5%) | 1609 (93.0%) | < 0.001 |
> 100 | 296 (10.1%) | 174 (14.5%) | 122 (7.1%) | |
SBP - mmHg | 124.0 ± 18.1 | 125.0 ± 17.9 | 124.0 ± 18.2 | 0.145 |
LEDVT limb | ||||
Left limb | 1776 (60.6%) | 677 (56.5%) | 1099 (63.5%) | < 0.001 |
Right limb | 745 (25.4%) | 301 (25.1%) | 444 (25.6%) | |
Bilateral limbs | 408 (13.9%) | 220 (18.4%) | 188 (10.9%) | |
LEDVT type | ||||
Proximal | 2486 (84.9%) | 1056 (88.1%) | 1430 (82.6%) | < 0.001 |
Distal | 443 (15.1%) | 142 (11.9%) | 301 (17.4%) | |
Comorbidities | ||||
Chronic heart failure | 128 (4.4%) | 86 (7.2%) | 42 (2.4%) | < 0.001 |
Paralytic stroke | 136 (4.6%) | 54 (4.5%) | 82 (4.7%) | 0.841 |
Autoimmune disease | 143 (4.9%) | 55 (4.6%) | 88 (5.1%) | 0.602 |
Nephrotic syndrome | 56 (1.9%) | 33 (2.8%) | 23 (1.3%) | 0.008 |
Risk factors | ||||
Malignant tumor | 379 (12.9%) | 161 (13.4%) | 218 (12.6%) | 0.539 |
Immobilization | 813 (27.8%) | 311 (26.0%) | 502 (29.0%) | 0.078 |
Fracture of lower limb | 261 (8.9%) | 117 (9.8%) | 144 (8.3%) | 0.199 |
Leg varicosities | 161 (5.5%) | 59 (4.9%) | 102 (5.9%) | 0.295 |
Pregnancy/postpartum | 120 (4.1%) | 39 (3.3%) | 81 (4.7%) | 0.058 |
Infection | 199 (6.8%) | 119 (9.9%) | 80 (4.6%) | < 0.001 |
Blood transfusion | 123 (4.2%) | 52 (4.3%) | 71 (4.1%) | 0.823 |
Smoking | 739 (25.2%) | 322 (26.9%) | 417 (24.1%) | 0.096 |
D-dimer-µg/mL | 4.4 (1.7–9.9) | 5.8 (2.6–11.7) | 3.6 (1.1–8.6) | < 0.001 |
AADD positive | 2552 (87.1%) | 1124 (93.8%) | 1428 (82.5%) | < 0.001 |
IVCT | 374 (12.8%) | 192 (16.0%) | 182 (10.5%) | < 0.001 |
